miltefosine has been researched along with Cancer of Prostate in 3 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Suramin has shown antitumour activity in vitro and in vivo." | 1.29 | The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin. ( Lopez Lopez, R; Peters, GJ; Pinedo, HM; van Rijswijk, RE; Wagstaff, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jangir, S | 1 |
| Bala, V | 1 |
| Lal, N | 1 |
| Kumar, L | 1 |
| Sarswat, A | 1 |
| Kumar, A | 1 |
| Saini, KS | 1 |
| Sharma, V | 1 |
| Verma, V | 1 |
| Maikhuri, JP | 1 |
| Konwar, R | 1 |
| Gupta, G | 1 |
| Sharma, VL | 1 |
| Wnętrzak, A | 1 |
| Lipiec, E | 1 |
| Łątka, K | 1 |
| Kwiatek, W | 1 |
| Dynarowicz-Łątka, P | 1 |
| Lopez Lopez, R | 1 |
| van Rijswijk, RE | 1 |
| Wagstaff, J | 1 |
| Pinedo, HM | 1 |
| Peters, GJ | 1 |
3 other studies available for miltefosine and Cancer of Prostate
| Article | Year |
|---|---|
Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Ditiocarb; Drug Sc | 2014 |
Affinity of alkylphosphocholines to biological membrane of prostate cancer: studies in natural and model systems.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Humans; Male; Models, Biological; | 2014 |
The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Divisi | 1994 |